Rotch Library - DE60.T48 2016

Rotch Library - HQ799.2.P6 M345 2016

Rotch Library - DP302.A5 B38 2016

Rotch Library - KKT5341.A197 V37 2016

Rotch Library - DS247.A135 E54 2016

Rotch Library - JQ3831.N3313 2016

Rotch Library - DT266.94.M378 2017

Rotch Library - BL580.C46 2015

Rotch Library - DS109.4.K45 2019

Rotch Library - N5975.A53 2017

With the emergence of coronavirus disease 2019 (COVID-19) as a global pandemic, individuals with preexisting chronic health conditions such as hypertension, diabetes, and cardiovascular disease have been identified as particularly vulnerable. These patients are also more likely than the general population to be taking angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs). As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus that causes COVID-19 gains entry into cells via binding to the angiotensin-converting enzyme 2 (ACE2) receptor, concerns have been raised that these therapies might facilitate the transmission of the virus or affect outcomes adversely. Given that ACEI and ARB therapies are known to provide benefit for the underlying conditions treated, stopping ACEI/ARB therapy carries risks. Moreover, local inactivation of the renin-angiotensin-aldosterone system may have protective effects against the development and progression of acute lung failure. In the absence of clinical evidence of benefit or risk of ACEIs/ARBs, current societal statements recommend against discontinuing these drugs other than for standard clinical indications. Robust clinical data are needed to clarify the effect of ACEIs/ARBs on SARS-CoV-2 infection.

This cohort study assesses the association between use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with the likelihood of testing positive for coronavirus disease 2019 (COVID-19).

This decision analytical model quantifies the projected gains for deaths prevented or postponed with comprehensive implementation of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) therapy for patients with heart failure with reduced ejection fraction in the United States.

Johnsonville, LLC., a Sheboygan Falls, Wis. establishment, is recalling approximately 95,393 pounds of its ready-to-eat jalapeño cheddar smoked sausage products that may be contaminated with extraneous material, specifically hard green plastic.

Tyson Foods, Inc., a New Holland, Pa. establishment, is recalling approximately 190,757 pounds of ready-to-eat chicken fritter products that may be contaminated with extraneous materials, specifically hard plastic.

The U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) is urging everyone to be food safe as they cook out this Fourth of July by to keep the celebration free from illness-causing bacteria.

Fieldsource Food Systems, Inc., a Brea, Calif. establishment, is recalling approximately 12,953 pounds of diced beef and chicken products due to misbranding and undeclared allergens.

Tyson Foods Inc., a Pine Bluff, Ark. establishment, is recalling approximately 39,078 pounds of Weaver brand frozen chicken patty product that may be contaminated with extraneous materials.

BCI Foods, Inc., a Quebec, Canada firm and importer of record, is recalling approximately 3,304 pounds of meat and poultry soup products that were not presented for import re-inspection.

Kenosha Beef International, a Columbus, Ohio establishment, is recalling an undetermined amount of seasoned beef products that may be contaminated with extraneous materials.

The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for chicken soup products imported from Canada that were produced by Canyon Creek Soup Co. Ltd., a Canadian establishment, because the products are misbranded and contain wheat and soy, known allergens, which are not declared on the product label.

The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert due to illnesses caused by Listeria monocytogenes associated with FDA-regulated hard boiled eggs that have been recalled by Almark Foods.

Kettle Cuisine Midco, LLC, a Lynn, Mass. establishment, is recalling approximately 200 pounds of ready-to-eat (RTE) lentil and beef soup products due to misbranding and undeclared allergens.

The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert due to illnesses caused by Listeria monocytogenes associated with FDA-regulated hard boiled eggs that have been recalled by Almark Foods.

The medicinal soap brand is seeing a sharp spurt in demand across the country

Google, Twitter, TikTok, Facebook team up with global health agencies and governments to put up the guardrails on the fake trail

Edtech brands offer discounts, add fresh content and engage more frequently with users

Reliance Group Chairman Anil Ambani has been inducted into the international advisory board of global think-tank The Atlantic Council.

Hobson, Fred C, 1943-

Van Dover, J. Kenneth

Johnson, Daisy, 1990- author

Sohmer, Steve (Stephen T.), author

Robson, Colin, author

Entzminger, Betina, 1967- author

Nelson, Alice, 1980- author

Price, Cheryl Blake, author

Winterson, Jeanette, 1959- author

Sorensen, Tracy, author

Hall, Rodney, 1935- author

Jack, Alison M., author

McCammon, Robert R., author

Skillman, Crystal, 1974- author

Nelson, Maggie, 1973- author

McAvan, Emily, author